AstraZeneca makes deal with Chinese biotech Usynova
The Anglo-Swedish pharmaceutical company, AstraZeneca has made a deal with Chinese biotech Usynova. The Chinese company announced a licensing agreement with AstraZeneca for the clinical-stage small molecule KRASG12D inhibitor UA022. …
AstraZeneca makes deal with Chinese biotech Usynova Read More